The prevalence of hearing impairment in the 6 months-5 years HIV/AIDS-positive patients attending paediatric infectious disease clinic at Mulago Hospital. 2013

Ndoleriire Christopher, and Turitwenka Edward, and Bakeera-Kitaaka Sabrina, and Nyabigambo Agnes
Makerere University, College of Health Sciences, Department of ENT, P.O. Box 7072, Makerere College of Health Sciences, Kampala, Uganda. nchris2k@yahoo.com

BACKGROUND Hearing impairment is one form of disability in children living with HIV/AIDS. It greatly interferes with their language development, communication and performance. These are stressful to the children and their caretakers. With increasing availability of free anti-retroviral therapy, children with HIV/AIDS are living much longer. Therefore efforts must be made to reduce the disability resulting from hearing impairment among children living with HIV. OBJECTIVE The objective of this study was to determine the prevalence, types and severity of hearing loss in HIV positive pediatric patients between 6 months and 5 years of age attending PIDC, Mulago Hospital Uganda. METHODS This was a descriptive cross sectional study among 370 HIV/AIDS pediatric patients between 6 months and 5 years of age at PIDC Mulago. In this study, hearing impairment was defined as any auditory brainstem response (ABR) average threshold of over 25 dBnHL at frequencies of 500 Hz to 4000 Hz. This was done using a VIVOSONIC VIVOLINK ABR machine and a tympanogram was acquired from each ear. Systematic random sampling was carried out to reach individual participants. Proportions were used to estimate prevalence of hearing impairment in this age group. RESULTS A total of 370 participants were recruited, with mean age of 38 months and median age of 36 months. The ratio of male to female was 1:1. The majority 172/370 (46.5%) of the participants were of WHO stage III. The prevalence of hearing loss in the 6 months to 5 years HIV/AIDS positive patients was found to be 121/370 (33.0%). The majority 77/121 (64.0%) of the participants had sensorineural hearing loss (SNHL). Of these with SNHL 44% had mild (26-40 dBHL) hearing loss. CONCLUSIONS The prevalence of hearing among pediatric HIV/AIDS patients between the 6 months and 5 years was found to be high with sensorineural hearing loss being the most prevalent. Therefore HIV/AIDS paediatric patients should have routine screening for hearing impairment. A prospective cohort study should be designed to assess the risk of acquisition of hearing loss in children living with HIV.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D014454 Uganda A republic in eastern Africa, south of SUDAN and west of KENYA. Its capital is Kampala. Republic of Uganda
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

Ndoleriire Christopher, and Turitwenka Edward, and Bakeera-Kitaaka Sabrina, and Nyabigambo Agnes
September 2005, African health sciences,
Ndoleriire Christopher, and Turitwenka Edward, and Bakeera-Kitaaka Sabrina, and Nyabigambo Agnes
March 2011, African health sciences,
Ndoleriire Christopher, and Turitwenka Edward, and Bakeera-Kitaaka Sabrina, and Nyabigambo Agnes
January 2018, AIDS research and therapy,
Ndoleriire Christopher, and Turitwenka Edward, and Bakeera-Kitaaka Sabrina, and Nyabigambo Agnes
August 2003, African health sciences,
Ndoleriire Christopher, and Turitwenka Edward, and Bakeera-Kitaaka Sabrina, and Nyabigambo Agnes
January 2014, The Pan African medical journal,
Ndoleriire Christopher, and Turitwenka Edward, and Bakeera-Kitaaka Sabrina, and Nyabigambo Agnes
June 2019, Diabetes research and clinical practice,
Ndoleriire Christopher, and Turitwenka Edward, and Bakeera-Kitaaka Sabrina, and Nyabigambo Agnes
August 2022, African health sciences,
Ndoleriire Christopher, and Turitwenka Edward, and Bakeera-Kitaaka Sabrina, and Nyabigambo Agnes
June 2022, BMC pediatrics,
Ndoleriire Christopher, and Turitwenka Edward, and Bakeera-Kitaaka Sabrina, and Nyabigambo Agnes
January 1992, Journal of acquired immune deficiency syndromes,
Copied contents to your clipboard!